R1 RCM Inc (RCM)
12.87
-0.12
(-0.92%)
USD |
NASDAQ |
May 31, 16:00
12.86
-0.01
(-0.08%)
After-Hours: 20:00
R1 RCM Free Cash Flow: 228.60M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | 228.60M |
| December 31, 2023 | 237.60M |
| September 30, 2023 | 150.90M |
| June 30, 2023 | 68.20M |
| March 31, 2023 | -93.00M |
| December 31, 2022 | -103.40M |
| September 30, 2022 | -94.70M |
| June 30, 2022 | -13.50M |
| March 31, 2022 | 189.30M |
| December 31, 2021 | 204.80M |
| September 30, 2021 | 187.80M |
| June 30, 2021 | 106.50M |
| March 31, 2021 | 59.70M |
| December 31, 2020 | 10.60M |
| September 30, 2020 | 60.90M |
| June 30, 2020 | 55.40M |
| March 31, 2020 | -16.10M |
| December 31, 2019 | 52.90M |
| September 30, 2019 | 11.10M |
| June 30, 2019 | 32.90M |
| March 31, 2019 | 54.40M |
| December 31, 2018 | -15.20M |
| September 30, 2018 | -4.40M |
| June 30, 2018 | -3.00M |
| March 31, 2018 | 11.10M |
| Date | Value |
|---|---|
| December 31, 2017 | -12.70M |
| September 30, 2017 | -54.20M |
| June 30, 2017 | -86.00M |
| March 31, 2017 | -135.60M |
| December 31, 2016 | -99.50M |
| September 30, 2016 | -112.97M |
| June 30, 2016 | -77.17M |
| March 31, 2016 | -28.46M |
| December 31, 2015 | -45.10M |
| September 30, 2015 | -60.05M |
| June 30, 2015 | -35.87M |
| March 31, 2015 | -79.40M |
| December 31, 2014 | -83.27M |
| September 30, 2014 | -26.38M |
| June 30, 2014 | -49.30M |
| March 31, 2014 | 25.13M |
| December 31, 2013 | 52.55M |
| September 30, 2013 | 59.65M |
| June 30, 2013 | 49.54M |
| March 31, 2013 | 14.61M |
| December 31, 2012 | 18.62M |
| September 30, 2012 | 13.49M |
| June 30, 2012 | 35.53M |
| March 31, 2012 | 61.52M |
| December 31, 2011 | 4.296M |
Free Cash Flow Range, Past 5 Years
-103.40M
Minimum
Dec 2022
237.60M
Maximum
Dec 2023
66.82M
Average
57.55M
Median
Free Cash Flow Benchmarks
| Panamera Holdings Corp | -0.175M |
| Thermo Fisher Scientific Inc | 7.56B |
| TruBridge Inc | -32.62M |
| PetMed Express Inc | 1.725M |
| LENZ Therapeutics Inc | -72.77M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 46.70M |
| Cash from Investing (Quarterly) | -698.40M |
| Cash from Financing (Quarterly) | 656.10M |
| Free Cash Flow Per Share (Quarterly) | 0.053 |
| Free Cash Flow to Equity (Quarterly) | -615.00M |
| Free Cash Flow to Firm (Quarterly) | 65.83M |
| Free Cash Flow Yield | 4.07% |